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A B S T R A C T 
Mathematical models of tumor- immune interactions provide an analytical 
framework by which to address specific questions about tumor- immune dynamics. W e 
present an extension of a mathematical model developed by De Pillis et al. that accounts 
for the immune surveillance of tumors by natural killer (NK) cells and cytotoxic CD8+ T 
lymphocytes (CTL's ) . N K cells mediate an innate immune response against cancer 
because N K cells can respond to tumor cells without the need for prior antigen-specific 
stimulation, while CTL ' s mediate an adaptive immune response because they require 
antigen-specific stimulation before responding effectively. Our extended model 
incorporates state transitions between naive and primed CTL ' s and cytokine signaling 
between N K cells and CTL ' s . In addition, the model describes tumor- immune 
interactions focusing on the roles of the innate and adaptive immune responses in tumor 
immune surveillance. The mathematical model describes tumor- immune interactions by 
utilizing a system of non-linear differential equations with respect to tumor cells, N K 
cells, CTL ' s , and antigen presenting cells. The functions describing tumor- immune 
growth, antigen presentation, immune response, and interaction rates are numerically 
simulated with a differential equation solver (GNU Octave). Parameter estimates and 
model validations are obtained from prior mathematical papers and medical studies 
related to this topic. We expect that both the innate and adaptive immune systems play 
independent and synergistic roles to defend the body from cancer. 
I dedicate this thesis to my parents and m y mentor for their support in my work. I 
thank Sigma Xi, the Scientific Research Society, for their support through their Grant-In-
Aid of research program. 
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INTRODUCTION 
Immunology is a broad field that seeks to understand the physiological mechanisms 
necessary to defend an organism against pathological invaders during states of both 
health and disease (Abbas et al. 2010). Before the advent of immunology, early 
physicians characterized various human organs that would later be deemed necessary for 
immunological defense; for example, the human immune system relies upon the 
cardiovascular system (heart, arteries, and veins), the thymus, the skin, as well as lymph 
vessels. Immunology can trace its origins back to ancient times where many civilizations 
utilized various techniques to prevent disease; for example, the Chinese (1300 BC) 
became resistant to smallpox by inhaling powders generated from skin lesions of the 
infected (Abbas et al. 2010). As immunology developed into an experimental science, it 
has discovered the nature of pathogenic invaders (viruses, bacteria, etc); pathogens have 
evolved mechanisms to subvert some aspect of a host immune system or acquired 
resistance to a variety of antibiotics or medicines, for example, penicillin. 
Due to the complexity of foreign invaders, the human innate immune system has 
to present a variety of defenses to prevent and combat infection. The first defense that 
prevents pathogenic entry is an epithelial barrier, which is a physical barrier that prevents 
pathogenic movement from the external environment to host tissue (Linton 2008). 
Depending upon the site of entry, pathogens will encounter extra defenses in addition to 
the physical barrier; for example, if a pathogen tries to invade through the vaginal tract, it 
will encounter an acidic pH of 4.5 due to the high proton concentration contained in 
vaginal fluid (Abbas et al. 2010). Other barriers may have other defenses, for example 
secretion of lysozymes or defensins (cysteine-rich peptides), that disrupt the cell 
membranes of fungi and bacteria and kill them. 
Pathogenic invaders will overcome the defenses epithelial barriers present and 
will gain entry; however, the next defense that a pathogen will encounter is circulating 
effector cells, such as macrophages, natural killer cells, or neutrophils. Before a 
circulating effector cell can digest or lyse a foreign invader, recognition must first be 
established in order to discriminate self from non-self (Abbas et al 2010). Circulating 
effector cells contain a variety of surface receptors that recognize pathogen associated 
molecular patterns, which are cell surface or soluble molecules that can initiate a signal 
transduction cascade (Abbas et al, 2010). Examples of surface receptors can include 
(Abbas et al. 2010): 
• Toll-like receptors - these receptors recognize a variety of pathogenic molecules. 
• C-type lectins - these receptors recognize bacterial surface carbohydrates with a 
terminal sugar 
• N-formyl-Met-Leu-Phe - these receptors recognize surface peptides with N -
formylmethionyl residues 
Signaling cascades can result in activation of host defense, cell recruitment, and 
inflammation (Abbas et al. 2010). 
Once recognition has been established between the pathogen and effector cell, 
various courses of action may be taken to eliminate the pathogen. Leukocytes and 
macrophages can phagocytize and kill the pathogen by fusing the newly created 
phagosome with a lysosome containing reactive oxygen species (ROS) (Abbas et al 
2010). Other actions that macrophages can perform include the secretion of cytokines 
(small peptides) that stimulate inflammation at the infection site or cell recruitment to 
overwhelm the pathogen. Natural killer (NK) cells can recruit macrophages to the 
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infection site through the secretion of cytokines or kill viral infected cells through a 
signal transduction process that results in apoptosis (Abbas et al. 2010). 
Another defense that pathogens can encounter is the complement system, which is 
a system of circulating effector proteins that is activated in the presence of pathogens. 
Complement contains a series of inactivated proteins that circulate in plasma; however, in 
the presence of a pathogen, it results in the rapid, sequential activation of complement 
proteins that can assist effector cells by recruiting macrophages, promote inflammation, 
as well as promote lysis of microbes through the formation of the membrane attack 
complex, a protein assembly that forms holes in the membrane of a pathogen, inducing 
free diffusion of molecules outward into the plasma (Abbas et al. 2010). If enough 
membrane attack complexes assemble on the surface of a pathogen, then the resulting 
water imbalance will kill the pathogen. Three pathways can activate the complement 
system as follows (figure 1): 
• Alternative - complement protein is cleaved and activated on the surface of the 
pathogen 
• Classical - antibody binding, via the adaptive immune system, activates 
complement cleavage 
• Lectin - sugar proteins bind on surface residues on the pathogen 's surface to 
activate complement cleavage 
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Figure #1: Overview of the complement system (Adapted from Abbas et al. 2010). Activation of 
the complement system by pathogens results in a variety of effector function mediated by cleaved 
complement proteins. C3 convertase cleaves C3 into two fragments, which act to promote 
inflammation, to deter pathogenic movement, and opsonization, a process in which pathogens 
are targeted for phagocytosis. During the latter stages of the complement response, another 
complement protein C5 is cleaved by C5 convertase and the fragments result in inflammation and 
the formation of the membrane attack complex, which promotes pathogenic death via osmosis. 
Each pathway activates C3 Convertase, which is a protein dimer composed of two 
complement proteins that acts to promote successive cleavage of complement proteins. 
All pathways lead to the same result of inflammation, cell recruitment, as well as the 
formation of the membrane attack complex. 
If the innate system cannot deter pathogenic invasion in a host, then the adaptive 
immune system must be primed via antigen presentation in order to take over immune 
functions. Unlike the innate immune system, the adaptive immune system deters 
pathogenic attack through activation of lymphocytes of B and T cell lineages (Abbas et al. 
2010). Activation of B and T cells requires a cell (dendritic, macrophage, B cell, etc.) that 
has the capacity to convert an antigenic substance (protein, sugar, or cell residue) into a 
polypeptide signaling molecule and present via a major histocompatability complex 
molecule (MHC). M H C molecules can be classified as the following: 
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• Class I - Receptor generated from degraded viral proteins in the cytosol, via 
proteosomes, and activates C D 8 + Cytotoxic T lymphocytes (CTL) 
• Class II - Receptor generated in response to extra cellular bacteria and activates 
C D 4 + Helper T lymphocytes (HTL) 
• Class III - Encodes for other immune components such as complement 
components, heat shock proteins, and cytokines to promote cell recruitment as 
well as inflammation 
All nucleated cells in the immune system encode M H C class I receptors, while B-cells, 
dendritic cells, and macrophages encode M H C class II receptors. 
C D 8 + Cytotoxic T lymphocytes perform the dirty work of cell-mediated immunity 
by activating apoptosis in an infected, damaged, or dysfunctional cell. Once M H C class I 
molecules from an infected cell interacts with a naive CTL, the CTL becomes primed and 
releases perforin and granulysin proteins, which create a osmotic gradient capable of lysis, 
as well as serine proteases to induce apoptosis. To prevent extensive damage during an 
infection, CTL activation is heavily regulated and requires a strong MHC/ant igen affinity 
as well as HTL surface proteins (Abbas et al. 2010). Upon remission of a pathogenic 
attack, most of a CTL population is destroyed except for a few remnants that are retained 
as memory cells, which can quickly regenerate and eliminate a pathogenic attack. 
Unlike CTLs, HTLs mediate immunity by maximizing the adaptive immune 
response of CTL activation and cell recruitment via cytokine secretion. Once a M H C 
class II molecule from an infected cell interacts with a naive HTL, the HTL becomes 
primed and differentiates into one of three forms: 
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• Effector - These cells secrete cytokines to stimulate circulating effector CTL, 
HTL, B cells, and macrophages 
• Memory - These cells retain the affinity of the MHC/antigen of the original 
cell and can be reactivated during a secondary immune response. 
• Regulatory - These cells regulate the cell-mediated response by suppressing 
CD8 and CD4 functionality. 
Depending upon the partner cell that attaches to the naive HTL, the pr imed 
effector cell will release various chemokines and cytokines. For example, a macrophage 
will induce interleukin-2 and interleukin-10 (IL) secretion that stimulates the recruitment 
of circulating CTLs and macrophages, while a B cell will induce IL-4, IL-5, IL-6, IL-10, 
and IL-13 secretion to promote antibody class switching as well as increasing antibody 
production (Abbas et al. 2010). Unlike effector HTLs, memory HTLs remain in 
dormancy after being primed in order to retain the affinity of MHC/ant igen binding; 
however, during a secondary immune response, memory HTLs can differentiate into 
other subpopulations to respond to a pathogenic attack much faster than the first response. 
Regulatory HTLs, unlike the other two classes, can be beneficiary and detrimental 
to the immune process depending upon the ailment encountered. Regulatory HTLs act in 
bystander suppression by hindering MHC/ant igen attachment as well as suppressing IL-
10 and tumor necrosis factor secretion to stop cell recruitment (Abbas et al. 2010). 
Inhibition of certain cell-mediated functions is necessary to maintain homeostasis in an 
individual; however, inhibition can create a "sl ippery-slope" since too much inhibition 
leads to chronic disease, while too little inhibition leads to autoimmune disorders. 
The cancer immunosurveil lance hypothesis has had a long history of development 
since the early 20 century. In 1909, Paul Ehrlich, a German scientist, proposed the idea 
that the immune system could suppress an overwhelming number of carcinomas (Dunn 
et al. 2004). This idea was not well tested until the early 1950's when the field of 
immunology had matured. Early research in mouse-bred lines discovered that Ehrl ich 's 
hypothesis did not refer to tumor immunology and instead proved the theory of allograft 
rejection; however, research in the latter 2 0 t h century supported Ehrl ich 's hypothesis as 
many laboratories demonstrated that mice could become immunized against cancer 
through allograft transplantation of tumors with chemical carcinogens. This discovery 
provided the cornerstone of the cancer immunosurveil lance hypothesis since tumor 
antigens present in an individual 's immune system are required to elicit an immune 
response; if no distinctive structures associated with tumor cells exist, then no recognition 
would be established (Dunn et al. 2004). F. Macfarlane Burnet and Lewis Thomas, well-
known immunologists during the late 2 0 t h century, speculated that for caner 
immunosurveil lance to work, lymphocytes would need to act aggressively in order to 
recognize and eliminate a cancer threat. Cancer immunosurveillance theory revolves 
around the three " E ' s " (Figure 2), which are (Dunn et al. 2004): 
• Elimination - The establishment of a strong cancer surveillance network by 
both the innate and adaptive immune system which seeks to eliminate cancer 
populations 
• Equilibrium - The long term process of combat between a cancer population 
and the cancer surveillance network 
• Escape - The overpowering of the cancer surveillance network by strong 
tumor variants, which results in host death 
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Figure #2: Overview of the cancer immunosurveillance hypothesis (Adapted from Dunn et al. 
2004). Cancer immunosurveillance arises from deleterious mutations in the regulatory system of 
the cell cycle mainly caused due to many factors such as carcinogens or radiation. Transformed 
cells have their cell cycle put in "overdrive" and result in a cell growth explosion resulting in the 
formation of cancer. Innate and adaptive immunity then activates in response to this process and 
both seek to destroy newly formed cancer populations. Cancer immunosurveillance starts in the 
"elimination" phase in which components of innate and cell mediated immunity seek to hinder 
cancer propagation; however, if cancer populations can evade immune surveillance by producing 
different antigen epitopes that the immune system cannot recognize, then "elimination" transitions 
to "equilibrium." "Equilibrium" is the second phase in which innate and cell mediated immunity are 
in check with cancer populations. The cancer immunosurveillance response does not have a 
profound impact on cancer propagation since the immune system is overwhelmed with 
processing different antigens cancer cells produce as a result of mutation in the antigen 
conversion process. Thus, the cancer immunosurveillance response has to keep up at a fast 
pace due to the diversity in cancer antigen production and processing; however, if a host's 
immune system cannot process antigens anymore, then cancer can overwhelm the host and 
"equilibrium" transitions to "escape." "Escape" is the final phase in which a host's immune system 
cannot contain a cancer population. Cancer escapes, due to immune inhibition by T regulatory 
cells, and the result is host death. 
In this thesis, I present a mathematical model that describes the conditions in 
which the three " E ' s " exist in the cancer immunosurveil lance hypothesis between cancer 
populations as well as the innate and adaptive immune systems. W e expect that both the 
innate and adaptive immune systems play independent and synergistic roles to defend the 
body from cancer. 
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M E T H O D S 
The biological assumptions taken into consideration during the development of 
this model are based on accepted knowledge of immune function, which include: 
1. Tumor cells grow exponentially in absence of an immune response. This 
assumption is based on prior work. Other forms of population growth such as 
logarithmic growth have been considered during the development of this model; 
however, exponential growth was chosen since it is the simplest form to go along 
with the cancer immunosurveil lance hypothesis (Edelstein-keshet 2005). 
2. Both N K and CTL cells can kill tumor cells. 
3. Tumor cells can have the potential to elicit endogenous defenses in primed cells. 
Both N K and CTL cells respond to tumor cells by secreting various cytokines, 
interferon gamma as well as perforin proteins. The "effectiveness" of how well 
the innate and adaptive immune systems eliminate cancer depends upon the 
number of cells present as well as the cytotoxic potential of individual cells. This 
model does not evaluate the cytotoxic potential of each cell as a response to 
increases in cell number, but combines the two and measures the combined 
increase as a response to tumor cells. 
4. As with innate immunity, N K cells are abundant and constantly circulating in the 
immune system (de Pillis et al. 2005). 
5. With cell-mediated immunity, T cells are abundant in their naive stage and 
differentiate into C D 8 + Cytotoxic T lymphocytes, C D 4 + Helper T lymphocytes, 
and C D 4 + FoxP3 T regulatory lymphocytes after encountering tumor antigen by 
APC. Naive T cells derive from hematopoietic stem cells in bone marrow and 
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migrate to the thymus in which they both express CD4 and CD8 surface proteins. 
The thymus undergoes positive and negative selection to discriminate " s e l f from 
" n o n - s e l f reacting T cells in order to prevent an autoimmune disorder. " S e l f 
reacting cells are deactivated while " n o n - s e l f cells continue to develop and 
differentiate (Abbas et al. 2010). Overtime, one of the surface proteins, CD4 and 
CD8, are deactivated and naive T cells transition into a CTL, HTL, or a regulatory 
HTL. This model simplifies the thymus maturation process by allowing each 
specialized cell type to have their own naive populations and immediately 
transition into mature cells in presence of tumor antigen. 
6. The activation of cell-mediated immunity is regulated by tumor antigen 
acquisition by antigen presenting cells, such as Langerhan 's , B cells, and 
macrophages. 
7. CTLs, HTLs, and regulatory HTLs secrete IL-2 to activate and recruit circulating 
effector cells. 
8. Regulatory HTLs decrease CTL and H T L populations by inactivating cell 
activation or cytokine secretion. Current trends in immunology assume that 
inhibiting regulatory HTL function decreases the time in which immune cells 
interact with cancer. This model assumes that regulatory HTLs make up no more 
than five percent of cell-mediated immune populations, but still impact CTL and 
H T L function (Ahmadzadeh et al 2006). 
Utilizing the eight assumptions from above, the system can be described as ten 
coupled differential equations where each equation gives the rate of change of a 
11 
particular cell population in terms of growth and death, cell-cell kill, cell recruitment, and 
cell inactivation. In general: 
A population 
= (growth — death) + (recruitment — inactivation — cell kill) 
A time 
The eight above assumptions are, in essence, an improvement to a model 
proposed by Lisette G. de Pillis et al. in 2005 in which the primary investigator 
considered cancer immunosurveil lance based on interactions between cancer, CTL, and 
N K cell populations; however, their model did not consider deeper details of the 
hypothesis, such as H T L assistance, cytokine secretion, as well as T regulatory cell 
inhibition of CTLs and HTLs. The new model designated for this thesis is as follows: 
dC , 
-—= rcC - k±NC - k2TeC ( # 1 ) - Cancer Cells 
at 
Equation #1 describes the change of cancer populations in which the state variable 
of this equation is (C). Cancer populations propagate (r c ) at a fixed rate and die off due to 
cell -cell interactions between N K cells and C T L ' s (ki and K2). 
dN r NC 
— = bN - dNN + — — - - lnNC ( # 2 ) - NK Cells dt mn + C 
Equation #2 describes the change of N K cell populations in which the state 
variable of this equation is (N). N K cells are born at a fixed rate (bn) and die off (d^) in 
proportion to population levels. In addition, N K cells are recruited in response to cancer 
antigen presentation at a fixed rate (r n and m n ) as well as die off due to cell-cell 
interactions with cancer ( l n ) . 
dTn 
—- = bt - dtTn - maAvTn ( # 3 ) - Naive CDS dt 
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Equation #3 describes the change of naive CD8 populations in which the state 
variable of this equation is (T n ) . Naive CD8 populations are born at a fixed rate (b t) and 
die off (d t) in proportion to population levels. Naive CD8 populations then transition 
from the naive to primed states due to cancer antigen acquisition (m a ) by antigen 
presenting cells, which then present the processed cancer antigen to naive populations. 
= maApTn - dTTe + rTTeI2 - iTRTe ( # 4 ) - Effector CD8 dt 
Equation #4 describes the change of primed CD8 populations in which the state 
variable of this equation is (T e ) . Naive CD8 populations primed with cancer antigen 
transition from their naive to primed states to combat cancer (first term) and die off (dj) 
in proportion to population levels. Primed CTL populations are then influenced due to 
memory cell recruitment by interlukin-2 (rr) and are inhibited (ij) by T regulatory cells. 
= b h - dhHn - maApHn ( # 5 ) - Naive CD4 
Equation #5 describes the change of naive CD4 populations in which the state 
variable of this equation is (H n ) . Naive CD4 populations are born at a fixed rate (bh) and 
die off (dh) in proportion to population levels. Naive CD4 populations then transition 
from the naive to primed states due to cancer antigen acquisition (m a ) by antigen 
presenting cells, which then present the processed cancer antigen to naive populations. 
- p = maAvHn - dHHe + rHHeI2 - iHRHe ( # 6 ) - Effector CDA 
Equation #6 describes the change of pr imed CD4 populations in which the state 
variable of this equation is (H e ) . Naive CD4 populations primed with cancer antigen 
transition from their naive to primed states to combat cancer (first term) and die off (dj) 
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in proportion to population levels. Primed HTL populations are then influenced due to 
memory cell recruitment by interlukin-2 (rn) and are inhibited (in) by T regulatory cells. 
dh , . 
—— = c y 2 ~ dih — rH^eh ~ rT^eh ~ rRRh ( # 7 ) — Interlukin — 2 production 
at 
Equation #7 describes the change of interleukin-2 concentration in which the state 
variable of this equation is (I2). IL-2 is produced at a constant rate (Ci) by primed immune 
cells, mainly of HTL lineage, and is consumed in varying proportions ( r H , r T , and TR) to 
recruit circulating memory cells to combat cancer populations. In addition, IL-2 
denatures (di) in proportion to population levels. 
dA-Q 
—7=- = raC — daAp ( # 8 ) — Antigen Presnting Cells 
Equation #8 describes the change of antigen presenting cells in which the state 
variable of this equation is (A p ) . APC populations are primed (r a ) in a direct proportion to 
cancer antigen secretion and die off (d a ) in proportion to population levels. 
—7— = bR - dRRn - maAvRn ( # 9 ) - Naive CD4 FoxP3 
at y 
Equation #9 describes the change of naive T regulatory populations in which the 
state variable of this equation is (R n ) . Naive T regulatory populations are born at a fixed 
rate (L>R) and die off (dR) in proportion to population levels. Naive T regulatory 
populations then transition from the naive to primed states due to cancer antigen 
acquisition (m a ) by antigen presenting cells, which then present the processed cancer 
antigen to naive populations. 
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- p = maApRn - dRRe + rRReI2 ( # 1 0 ) - Effector CDA FoxP3 
Equation #10 describes the change of primed T regulatory populations in which 
the state variable of this equation is (Re). Naive CD4 populations primed with cancer 
antigen transition from their naive to primed states to inhibit host immune function (first 
term) and die off (dR) in proportion to population levels. Primed T regulatory populations 
are then influenced due to memory cell recruitment by interlukin-2 (TR), which aid in 
regulating the CTL and HTL response. 
GNU Octave, an open source math-modeling program, subjected the above model 
to numerical integration to determine the conditions in which cancer elimination, 
equilibrium, or escape might persist as well as determine "biologically" relevant 
parameter estimates for cancer immunosurveil lance via bifurcation analysis, which will 





Parameter Description Parameter 
value 
Reference 
r c(l/day) cancer propagation 5.41*10"' (de Pillis et al. 
2005). 
ki, k2, and ln 
(cell/day*nL) 





(de Pillis et al. 
2005). 
b N and dN 
(cell/day*nL) 
(1/day) 
birth (fixed) and death of NK cells 1.30*10~2 
4.12*10"8 
(Pillis et al. 2005). 
rn and mn 
(1/day) 
(cell2/nL) 
recruitment of circulating NK cells 2.50*10-* 
20.2 
(de Pillis et al. 
2005). 
m a ( 1/day) antigen presentation 1.00*10"4 (Kim et. al 2006) 
b, and dt 
(cell/nL*day) 
(1/day) 
birth and death rates of naive CD4 8.55 
3.00*10~8 
(Kim et. al 2006) 
dT, dH, and dR 
(1/day) 





(Kim et. al 2006) 
rT, rH, and r R 
(cell/nL*day) 
recruitment of circulating effector cells 3.75*10"8 
1.88*10'9 
(de Pillis et al. 
2005). 
i T and i H 
(1/day) 
inhibition of CD4 and CD8 activity by CD4 
FoxP3 
5.00*10"7 (de Pillis et al. 
2005). 
b h and dh 
(cell/nL*day) 
(1/day) 
birth and death rates of naive CD8 6.00 
3.00*10"8 
(Kim et. al 2006) 
b r and dr 
(cell/nL*day) 
(1/day) 
birth and death rates of naive CD4 FoxP3 4.50*10"5 
3.00* 10"8 
(Kim et. al 2006) 
Cj and di 
(l/day*nL) 
(1/day) 
production and degradation of IL-2 1.00*10'j 
i.oo*io-7 
(Kim et. al 2006) 
r a and da 
(1/day) 




(Kim et. al 2006) 
Table #1: Estimated parameter values incorporated into the above cancer immunosurveillance model. 
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RESULTS 
The above model can be used to simulate the conditions in which cancer 
immunosurveil lance falls under one of the three " E ' s " of the cancer immunosurveil lance 
hypothesis. Elimination, the first " E " of the immunosurveil lance hypothesis, requires 
antigen capture and presentation to activate this process. Once antigen recognition is 
established, cell-mediated immunity can intervene in cancer propagation, which is 
illustrated in figure 3: 
Figure #3: A hypothetical cancer immunosurveillance response with the following initial conditions 
C = 20,000 cells, N=2,500 cells, T n=H n= 1000 cells and R n=50 cells with Table #1 parameter 
values. 
In the stage of elimination, cancer propagation is assumed weak due to a strong 
host immune response (Dunn et al. 2004). Here, cancer populations (bolded blue) around 
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20,000 cells within a nanoliter of body fluid are rapidly eliminated due to a strong H T L 
and CTL proliferation and differentiation. Although the N K cell population (green) 
remains constant, intervention by N K cells of the innate immune system is only present at 
the beginning of the response. Cell mediated immunity takes over cancer 
immunosurveil lance after 100 days due to rapid antigen acquisition through N K cells 
secreting interferon-gamma as well as various chemokines that inhibit blood vessel 
formation (Dunn et al. 2004). Dead tumor debris is then acquired by APC cells (light blue 
line) that travel to the lymph nodes and prime naive T cells. There is rapid proliferation 
and recruitment after antigen presentation in which HTLs and CTLs migrate to the site of 
infection and deplete cancer populations. T regulatory cells see little action as they only 
make up five percent of lymphocyte populations. Although there is function, as shown by 
the model , T regulatory cells cannot inhibit the rapid expansion of mature CTL and HTL 
populations due to constant IL-2 secretion. 
Equilibrium, the second " E " of the cancer immunosurveil lance hypothesis, 
occurs immediately right after the elimination stage. In equilibrium, host immunity is at 
"even odds" with cancer populations in that cancer propagation is equal to host immune 
intervention. Cancer variants that survive the initial elimination stage rapidly proliferate 
until cancer populations match the host ' s immune response such that there is an 
equilibrium established between cancer division and death; equilibrium may also arise 
during the initial immune response if cancer cells mutate antigen variants that cannot be 





Figure #4: A hypothetical cancer immunosurveillance response with the following initial conditions 
C = 20,000 cells, N=2,500 cells, T n=H n= 1000 cells and R n=50 cells with Table #1 parameter 
values except for = 3.50*10"18 and k 2 = 4.60*10"11. The changes in k-i and k 2 values result from 
a strong cancer immunosurveillance response decaying overtime, reflecting the transition from 
"elimination " to "equilibrium," primarily due to cancer populations producing mutated antigen 
variants at a fast rate. Hence, cell-mediated immunity must produce CTLs and HTLs at a fast rate 
in order to keep up with the diversity of cancer antigens being produced. Because of antigen 
diversity, interactions between cancer, NK cells, and CTL's are weakened since primed cells with 
one specific type of cancer antigen can kill off cancer cells expressing the recognized antigen; 
however, cancer cells expressing a different type of antigen can avoid the cancer 
immunosurveillance response. Hence, the immunosurveillance process must process another 
type of antigen in order to kill off cancer cells that avoided the first immunosurveillance response. 
The transition from "elimination" to "equilibrium" results in cancer populations remaining constant 
during the immunosurveillance response. Please refer to Table #1 for parameter definitions and 
equation #1 to see how k-i and k 2 influences cancer populations. 
During equilibrium, tumor populations (blue) will spontaneously mutate in order 
to avoid A P C antigen acquisition; a mutation, whether it will affect a protein or one 
amino acid, can influence cancer immunosurveillance. T cell populations, both HTLs and 
CTLs, (green and tan) will differentiate and proliferate to survey host tissue that contains 
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cancerous cells that possess the recognized antigen; however, due to antigen mutation, T 
cells can no longer influence cancer dynamics. As tumor cells with recognized antigens 
are destroyed, those with mutated antigen can proliferate and maintain the population at 
equilibrium such that it undergoes a state of dormancy, which can last for about 20 years 
(Dunn et al. 2004). Parameter changes in figure 4 reflect a change in a hos t ' s defense or 
cancer propagation. As a host ' s defense weakens or cancer propagation ( r c - not shown in 
the above graph) strengthens, a host ' s immune system has to work twice as hard in order 
to maintain cancer populations in equilibrium (figure 4). A host ' s immune system will 
need to have the capability of producing T lymphocytes at a high rate in order to maintain 
cancer populations in check such that cancer remains in a benign state. In this case, a high 
cell proliferation and differentiation rate may not be feasible for a hos t ' s immune system. 
Escape, the third " E " of the cancer immunosurveil lance hypothesis, means death 
for the host immune response as cancer propagation overcomes host defenses and spreads 
beyond the area of infection, essentially hindering all host function. Cancer populations 
in this stage exponentially proliferate as according to figure 5: 
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Figure #5: Cancer immunosurveillance response with the following initial conditions 
C = 20,000 cells, N=2,500 cells, T n=H n= 1000 cells and R n=50 cells with Table #1 parameter 
values except for r c = 5.41*10~3. ^ = 3.50*10"18 and k 2 = 4.60*10~17. The changes in rc, k 1 f and k 2 
values result from cancer overwhelming a host's immunosurveillance response, reflecting the 
transition from "equilibrium " to "escape," primarily due a strong cancer propagation rate and a 
weakening immune response due to T cell inhibition and antigen processing. Because of antigen 
diversity and a strong cancer propagation rate, interactions between cancer, NK cells, and CTL's 
are weakened since primed cells with a specific type of cancer antigen can kill off cancer cells 
expressing the recognized antigen; however, cancer cells expressing a different type of antigen 
can avoid the cancer immunosurveillance response. In addition, T regulatory cells (not shown) 
inactivate CTLs and HTLs in order to maintain a host's homeostasis. Cancer populations can take 
these processes to their advantage and propagate at a fast rate, which results in host death. 
Please refer to Table #1 for parameter definitions and equation #1 to see how ki and k 2 
influences cancer populations. 
In the escape phase, cancer variants that have survived the equilibrium phase have 
successfully evolved escape mechanisms to avoid the host immune response and can now 
proliferate without regard to the host environment. Host immune response has severely 
weakened due to a variety of factors, such as FoxP3 regulatory inhibition and antigen 
switching, such that T cell populations (green and tan) grow at a slow rate and are 
eradicated at a faster rate than during the elimination and equilibrium stages. Tumor 
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variants have other mechanisms by which escape is possible, such as suppressive 
cytokines, to inactivate IL-2 secretion and stop host immune response (Dunn et al. 2004). 
Parameter changes in figure 5 reflect a change in a host ' s immune system or 
cancer propagation. As cancer propagation increases within a host, dormant cancer 
populations transition from a benign to an active state and the host undergoes a great deal 
of damage whether it be pancreatic, breast, or ovarian cancer. A host ' s immune system 
cannot catch up with a fast cancer propagation rate and in order to do so would need to 
have an overactive immune system, which is not physically possible due to T regulatory 
influence. As addressed above, T regulatory cells consist of only five percent of 
lymphocyte populations but can have a major influence on cancer immunosurveillance. 
As a host ' s immune function goes into overdrive, T regulatory cells will inactivate any 
cells that go beyond normal function; for example, targeting tissue cells in addition to 
cancer cells. T regulatory cells deactivate overactive CTLs or HTLs in order to maintain 
homeostasis and this response will result in host death. 
Bifurcation analysis, or parameter estimation, requires non-dimensionalization of 
a mathematical model to determine how computated solutions behave in regards to 
parameter switching. In the process of bifurcation analysis, relations between parameter 
and parameter "families" can be discovered and show how switching one can influence 
the behavior of another. Bifurcation analysis of the above model reveals three distinct 
families between cancer propagation (r c ) and host immune function as well as their 
behavior in figures 6 to 8: 
• R a and M a - Antigen production and acquisition (figure 6) 
• I T and I h - Inhibition of CTLs and HTLs by CD4 FoxP3 cells (figure 7) 
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• Q - Cytokine production (figure 8) 
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Figure #6 - A bifurcation diagram of cancer propagation against lymphocyte inhibition. Any 
values (rc, m a/r a) below the bolded blue line in the graph (rC( m a/r a) will result in cancer populations 
overcoming the host while values above the bolded blue line will result in the elimination of 
cancer. Note, any Ma and R a values below R c = 1.2 are not show to complete accuracy due to the 
high range of Ma and R a beyond R c = 1.2 
Antigen production by cancer cells (r a ) and antigen acquisition by APCs (m a ) are 
assumed to have linearity with cancer propagation (assumption #5) since each cancer cell 
produces one antigenic variant and APCs (B cells, etc.) quickly process a variant for cell-
mediated immunity activation. For values of r c between 0 <rc < 1.2, m a and r a values 
are between 0 < ma/ra < 30 due to linearity. Thus, for each secreted antigen from a 
cancer cell, an A P C must quickly process it to activate cell-mediated immunity. Thus, 
there are biologically relevant parameter values for m a and r a . Beyond rc > 1.2, 
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bifurcation analysis reveals biologically irrelevant parameters ranging from 30 < 
ma/ra < 1 * 1 0 8 0 This is primarily due to cancer propagation overwhelming a hos t ' s 
immune system by producing antigenic variants in greater numbers compared to APCs 
that can process them. Overwhelming of the APC process results in a compromised 
immune system and eventually host death. 
Figure #7 - A bifurcation diagram of cancer propagation against lymphocyte inhibition. Any value 
(rc, IT/'H) above the bolded blue line will result in cancer populations overcoming the host while 
values below the bolded blue line will result in the elimination of cancer. 
T regulatory cell inhibition and cancer propagation are assumed to have an 
inverse relationship similar to the function y = - . As cancer propagation increases within 
a host, from "equil ibrium" to "escape", the host ' s immune system must work twice as 
hard in order to prevent host death. A problem encountered during the transition from 
"equil ibrium" to "escape" is T cell regulation, which influences cancer 
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immunosurveillance by deactivating CTL sentinels and HTLs. Thus, in order to maintain 
cancer in the "equil ibrium" stage, T regulatory function must decrease in order for a host 
to prevent host death. For values of cancer propagation between 1 < rc < 2, T regulatory 
function ( i T and in) takes on values between 1 < iT/iH < 0.2, which indicates that in 
order for a host to maintain cancer in the equilibrium stage, inactivation of HTLs and 
CTLs must decrease to effectively combat cancer; however, if cancer propagation goes 
beyond rc > 2 there is a finite limit in which T regulatory function can be suppressed. 
From 2 < rc < 6 , the area of this interval is significantly smaller compared to the 
interval 1 < rc < 2, which indicates that a host can tolerate T regulatory suppression for 
so long to deter cancer propagation until cancer overcomes a host ' s immune machinery. 
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Figure #8 - A bifurcation diagram of cancer propagation against cytokine secretion. Any value (rc, 
C|) below the bolded blue line will result in cancer populations overcoming the host while values 
above the bolded blue line will result in the elimination of cancer. 
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Cytokine secretion and cancer propagation are assumed to have a hyperbolic 
(XX 
relationship similar to the Michaelis-Menten function y = ^—. Cytokine secretion is an 
important process in cancer immunosurveil lance as this protein family is essential for T 
cell recruitment of circulating HTLs, CTLs, and T regulatory cells and other immune 
processes. For values of r c between 0 < rc < 10 , Q values are between 0 < Q < 7; 
however beyond rc > 10 , Cj remains constant around seven, which indicates saturation. 
This means no matter what value of r c a cancer population may have, cancer propagation 
can be deterred if cytokine secretion remains at seven or above; however, any value less 
than seven for any rc > 10 means that the host succumbs to death. 
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DISCUSSION 
Numerical analysis can give insightful information to a problem simply by 
varying initial conditions as well as parameter values, which is versatile since a 
mathematical model can adapt to any given situation, such as the model above and cancer 
immunosurveil lance. By varying only three parameters in the cancer equation ( r C ; k i , and 
k2), cancer and host immune populations can transition from "Elimination" to 
"Equil ibr ium" and to "Escape"; varying other parameters in the other nine equations, 
such as birth rates on the naive T cell populations, may give similar results that describe 
these transitions in cancer immunosurveillance. Variation of host immune or cancer 
parameters can give insight into the behaviors of all populations and hence, parameter 
and initial value switching can adapt, to a variety of cancer patients to describe their 
current cancer 's stage in cancer immunosurveillance. 
Mathematical modeling, however, has its limitations in terms of model building 
and adaptation. Model building can only incorporate as much relevant biological 
information and assumptions as it can since this can affect the analytic phase of model 
building. Complex models, such as the one above, cannot be easily solved by hand and 
instead require the use of numerical solvers to see how results behave; smaller models are 
easier to manipulate and solve by hand, but are a simplified "story" of the issue at hand. 
Since accuracy is more important than simplicity, a larger model was opted for this 
project 
Cancer immunosurveil lance is a complex immune process and more than a 
simplified mathematical model , such as the one above and the one proposed by Lisette G. 
de Pillis et al. (2005). As stated in the introduction, cancer immunosurveil lance is a 
complex process that requires antigen recognition in order to activate cell-mediated 
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immunity. Innate immunity, for example, can defend a host against cancer populations up 
to a certain degree (Lin et al. 2007). Thus, cell-mediated immunity needs to be activated 
on the instant of cancer recognition in order to assist innate immunity functions (Figures 
3-5); yet, innate immunity facilitates cell-mediated immunity activation through 
antigen/MHC class I binding. Hence, innate immunity plays an independent and 
synergistic role in cancer immunosurveillance. On the onset of cancer 
immunosurveil lance, figures 3 and 4 depict no change in natural killer populations since 
assumption 4 states " N K cells are abundant and constantly circulating in the immune 
system." Hence, the model sees little changes or activity in N K cell populations during 
the cancer immunosurveil lance response. If the model had several more equations to 
describe the innate immune responses (macrophages, complement, etc.), then innate 
immunity would play a larger role in cancer immunosurveillance; the only contribution 
innate immunity gives to the model to describe the cancer immunosurveil lance process is 
N K cell activity. 
Cell-mediated immunity, once activated, assists the weak innate immune response 
by killing off cancer and infected host cells via C D 8 + cytotoxic T lymphocyte 
interactions as well as C D 4 + helper T lymphocyte rolling recruitment by IL-2 secretion. 
Some specialized T lymphocyte subpopulations, however, can provide deleterious effects 
on cell-mediated immunity. FoxP3 C D 4 + T regulatory lymphocyte populations can 
hinder cell-mediated function in order to maintain homeostasis within a host if it 
perceives a lymphocyte 's response to an infection as too strong. Although not shown in 
figures 3 through 5, T regulatory cells consist only of five percent of a hos t ' s lymphocyte 
population. To have a strong influence to deter cancer immunosurveil lance, FoxP3 
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production would need to be greater than that of HTLs and CTLs, which is not 
biologically possible. Another population is C D Id natural killer T cells that can reside in 
both innate and adaptive immunity (Chaturvedi et al. 2011). Their role in cancer 
immunosurveillance theory is relatively unknown, due to its recent discovery, but this 
subpopulation is hypothesized to have a negative impact on cancer immunosurveil lance. 
C D l d - N K T lymphocytes recognize various pathogens that express CD Id and act on 
those populations, while pathogens that do not express CD Id can invade C D Id 
surveillance; this may facilitate the transition of cancer immunosurveil lance from 
"elimination" to "equil ibrium" or possibly "escape" in part of CD Id cells lacking in the 
diversity of antigen response compared to other cell populations. 
The three stages of cancer immunosurveil lance are unique in that each has its own 
outcome: 
• Elimination - The establishment of a strong cancer surveillance network by 
both the innate and adaptive immune system which seeks to eliminate cancer 
populations 
• Equilibrium - The long term process of combat between a cancer population 
and the cancer surveillance network 
• Escape - The overpowering of the cancer surveillance network by strong 
tumor variants, which results in host death 
By understanding the dynamics of each process, the results can have numerous 
applications in cancer diagnosis and cancer prevention since this model can be "tailored" 
to describe a patient 's condition. The cancer immunosurveil lance response is relatively 
not a quick process as the model depicts as cellular immune processes may take days, 
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weeks, months, or even years. The phases of "equil ibrium" and "escape" also follow 
similar parallels that of "el imination" (figures 4 and 5). In figure 3, cancer populations 
(blue bolded line - see above) start out at 20,000 cells and at the onset of the cancer 
immunosurveil lance response, immediately drop to zero cells around 1,500 days. In 
figure 4, cancer populations (blue bolded line - see above) stay constant around 20,000 
cells past 1,500 days and figure 5 depicts a surge in cancer populations starting around 
1,500 days. The model assumes days, rather than weeks or years, due to the time scale 
introduced into G N U Octave and its relative tolerance in computing the solutions for the 
above model; naturally, most mathematical models introduce an arbitrarily determined 
time scale (seconds, hours, etc.) to show that the results can be measured in any timescale. 
Regardless of the timescale, the ultimate goal of cancer immunosurveil lance is to 
protect the host from succumbing to many types of cancer. The main proponents of the 
cancer immunosurveil lance response are HTLs and CTLs primed after being exposed to 
cancer antigens by APCs (B cells, dendritic, etc.). In figure 3, H T L and CTL populations 
(green and tan lines - see above) rise as a response and kill off cancer populations, which 
follows the phase of "elimination." Figure 4 also sees a rise in HTL and CTL populations, 
but cancer populations stay at the same level around 20,000 cells, which follows the 
phase of "equil ibrium." Figure 5 sees hindered growth of CTL and HTL populations as 
cancer populations have successively evaded the cancer immunosurveil lance response, 
which follows the "escape" phase. These three figures can be thought of as three different 
patients with different types of cancer (pancreatic, prostate, colon, etc.) but with similar 
initial conditions and their immune systems at a different stage in cancer 
immunosurveil lance theory. Depending upon the abundance of CTLs, HTLs , T 
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regulatory cells, N K cells, cancer cells, and IL-2 concentrations, cancer 
immunosurveillance will be in either "elimination, equilibrium, or escape." 
Cellular dynamics can also affect cancer immunosurveillance. Changes in three 
parameters that specify cancer, CTLs, and N K cell interactions as well as cancer 
propagation can force the cancer immunosurveil lance response to switch between 
"elimination, equilibrium, and escape." In the model ' s context of "elimination," cancer 
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populations were eliminated due to kj and k2 values being 3.50*10" and 4.60*10" ; 
however, if kj and k2 were decreased to reflect a weakened immune response (ki= 
3.50*10" 1 8 and k 2 = 4 .60*10" n ) , then cancer immunosurveil lance transitions from 
"elimination" to "equilibrium," which results in less interactions between cancer, CTLs, 
and N K cells and cancer populations remaining constant. A further decrease of ki and k2, 
along with an increase in cancer propagation (r c ) , (r c = 5.41 *10" 3 , ki = 3.50* 10" 1 8 , and k2 
= 4.60* 10" 1 7) will result in transition from "equil ibrium" to "escape" and cancer wins 
resulting in host death. Therefore, the above mathematical model has established 
parameter conditions for cancer immunosurveil lance theory: 
• Elimination: kx > 3.50 * 10~ 1 2 ; k2 > 4.60 * 1 0 - 7 ; rc = 5.41 * 10" 7 
• Equilibrium: 3.50 * 10~ 1 8 < kt < 3.50 * 1 0 - 1 2 ; 4.60 * 1 0 - 1 1 <k2< 4.60 * 10" 7 
• Escape: kx = 3.50 * 10" 1 8 ; 4.60 * 10~ 1 7 <k2< 4.60 * 10" 1 1 ; 5.41 * 10" 7 <rc< 
5.41 * 1 0 - 3 
Bifurcation analysis can validate or provide new information to a subject that is 
being modeled. Figures 7 and 8, for example, show that cancer propagation can be 
hindered if cytokine production is increased (Figure 8) or T regulatory function is 
decreased (Figure 7), while figure 6 depicts antigen acquisition must rise in response to 
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cancer propagation. Figure 6 shows that antigen acquisition has to spontaneously rise in 
response to a faster cancer propagation rate; this proves impossible unless a host has 
accumulated a variety of mutations in his or her genome that will give rise to APCs with 
incredible function. Thus, any values beyond r c = 1.2 are biologically irrelevant since it is 
not possible for a host to produce APCs with such incredible function. 
Figures 7 and 8, however, show that if host cytokine production (figure 8) or T 
regulatory function (figure 7) is decreased, a host may have a better chance of survival 
due to enhanced immune function. Figure 7 shows that there is an inverse relationship 
between cancer propagation and CTL/HTL inhibition; this proves only possible if cancer 
immunosurveil lance is in "elimination" and "equil ibrium" where T regulatory cells have 
little influence on CTL and HTL function. Thus, all values of r c and ij/ln are biologically 
relevant since beyond r c = 6, T regulatory cells have a significant impact upon CTL and 
H T L function, which correlates with the escape phase. Figure 8 shows that that for 
increasing values of cancer propagation, cytokine secretion ( Q ) reaches saturation around 
a value of 7, which indicates that during the transition from "elimination" to "escape," a 
host needs to produce IL-2 in great concentrations in order to prevent death. Thus, only 
values of r c from 0 < rc < 10 are only biologically relevant since a host can only 
produce so much IL-2 during the cancer immunosurveil lance response; however, beyond 
rc > 10, this is only possible in a hospital setting, during the "escape" phase, where 
cytokine injections are needed to aid a critically ill patient. Regardless, bifurcation 
analysis of this non-dimensionalized model provides insightful information to the cancer 
immunosurveil lance response. For example medicines, such as cytokine injections 
(Margolin 2008) (figure 8) or T regulatory inhibitors (Ozao-choy et al. 2009) (figure 7), 
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may assist immunocompromised patients during the "escape" phase of cancer 
immunosurveillance. 
The future of this model is constant improvement since refinement is necessary to 
describe all processes of cancer immunosurveillance. Here, the model has shown that 
both the innate and adaptive immune systems play independent and synergistic roles in 
cancer immunosurveil lance as well as establish the conditions of the cancer 
immunosurveil lance hypothesis of "Elimination," "Equil ibrium," and "Escape" by 
varying three distinct parameters of the cancer equation; however, other parameter values 
may be varied to produce the same results. This model will most likely take part in a Ph. 
D. that will follow similar subject matter explored in this thesis. 
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